Fmr LLC Regeneron Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.81 Trillion
Q3 2025

A detailed history of Fmr LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,935,835 shares of REGN stock, worth $1.34 Billion. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,935,835

Previous 3,327,051 41.82%

Holding current value

$1.34 Billion

Previous $1.75 Billion 37.68%

% of portfolio

0.06%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$534.91 - $598.71 $744 Million - $833 Million	-1,391,216 Reduced 41.82%	1,935,835 $1.09 Billion
Q2 2025 Aug 14, 2025	SELL	$483.07 - $625.6 $2.06 Billion - $2.67 Billion	-4,271,533 Reduced 56.21%	3,327,051 $1.75 Billion
Q1 2025 May 12, 2025	SELL	$634.14 - $744.83 $381 Million - $448 Million	-600,995 Reduced 7.33%	7,598,584 $4.82 Billion
Q4 2024 Feb 13, 2025	SELL	$701.85 - $1046.91 $1.52 Billion - $2.26 Billion	-2,163,122 Reduced 20.87%	8,199,579 $5.84 Billion
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $294 Million - $345 Million	-286,773 Reduced 2.69%	10,362,701 $10.9 Billion

Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $128 Million - $155 Million	-144,598 Reduced 1.34%	10,649,474 $11.2 Billion
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $430 Million - $473 Million	476,657 Added 4.62%	10,794,072 $10.4 Billion
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $369 Million - $420 Million	476,523 Added 4.84%	10,317,415 $9.06 Billion
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $464 Million - $565 Million	669,517 Added 7.3%	9,840,892 $8.1 Billion
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $188 Million - $223 Million	-268,721 Reduced 2.85%	9,171,375 $6.59 Billion
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $1.13 Billion - $1.37 Billion	-1,656,895 Reduced 14.93%	9,440,096 $7.76 Billion
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $203 Million - $220 Million	287,245 Added 2.66%	11,096,991 $8.01 Billion
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $364 Million - $459 Million	633,547 Added 6.23%	10,809,746 $7.45 Billion
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $106 Million - $143 Million	193,175 Added 1.94%	10,176,199 $6.02 Billion
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $47.6 Million - $55.8 Million	-79,943 Reduced 0.79%	9,983,024 $6.97 Billion
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $546 Million - $674 Million	-1,004,984 Reduced 9.08%	10,062,967 $6.35 Billion
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $90.3 Million - $107 Million	157,257 Added 1.44%	11,067,951 $6.7 Billion
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $5.16 Billion - $6.09 Billion	10,910,694 New	10,910,694 $6.09 Billion

Others Institutions Holding REGN

# of Institutions

1,466

Shares Held

86.5M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account